Impact of Perceptive, Executive and Emotional Factors on Decision-making of Pedestrian Face to Autonomous Vehicles.
VASIS
1 other identifier
interventional
100
1 country
1
Brief Summary
The VASIS project aims to assess the impact of perceptual, executive and emotional factors on decision-making in the context of pedestrian crossing in an industrial environment involving autonomous vehicle traffic (forklift).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2024
CompletedNovember 26, 2024
April 1, 2024
3 months
February 5, 2024
November 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the impact of the attention of participants on decision-making in the context of pedestrian crossing (virtual reality), particularly on the time required to cross safely, in an industrial environment involving autonomous vehicle traffic.
Quantication of the time required for a pedestrian to cross safely, according to the attention of participants
Day 0
Study Arms (1)
pedestrian crossing - virtual reality
EXPERIMENTALInterventions
Neurocognitive tests (attention, executive functions, reaction to difficulty). Assessment of anxiety and impulsivity + pedestrian crossign with virtual reality + post-crossing questionnaire
Eligibility Criteria
You may qualify if:
- subjects aged 18 to 45
- no objection following submission of a non-objection form indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to comply with the requirements and restrictions inherent in the study
You may not qualify if:
- legal incapacity or limited legal capacity
- subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
- pregnant or breast-feeding women
- color-blind subject
- history of cardiovascular disease
- current psychiatric or neurological disorders (including self-reported diagnoses of epilepsy)
- known vestibular disorders (prone to frequent dizziness or vertigo)
- headaches or migraines
- deafness
- subjects under the influence of psychotropic substances (alcohol, drugs)
- motor disorders likely to prevent crossing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Besançon University Hospital
Besançon, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 13, 2024
Study Start
April 8, 2024
Primary Completion
July 8, 2024
Study Completion
July 8, 2024
Last Updated
November 26, 2024
Record last verified: 2024-04